Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity

Frontiers in Microbiology

Volumn 7, Issue MAY, 2016, Pages

  Payne, Jason N ^a   Waghwani, Hitesh K ^a   Connor, Michael G ^b   Hamilton, William ^a   Tockstein, Sarah ^a   Moolani, Harsh ^a   Chavda, Fenil ^a   Badwaik, Vivek ^a   Lawrenz, Matthew B ^b   Dakshinamurthy, Rajalingam ^a,c  

^a WESTERN KENTUCKY UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c AUSTIN PEAY STATE UNIVERSITY   (United States)

Author keywords

Antibacterial activity; Antibiotic resistance; Characterization; Gold nanoparticles; Kanamycin

Indexed keywords

KANAMYCIN; KANAMYCIN GOLD NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; ENTEROBACTER AEROGENES; FLUORESCENCE MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS EQUINUS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; YERSINIA PESTIS;

EID: 84973560649     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00607     Document Type: Article

References (64)

1. Ahmad, M. Z., Akhter, S., Rahman, Z., Akhter, S., Anwar, M., Mallik, N., et al. (2013). Nanometric gold in cancer nanotechnology: current status and future prospect. J. Pharm. Pharmacol. 65, 634-651. doi: 10.1111/jphp.12017
2. Akhtar, M. S., Panwar, J., and Yun, Y.-S. (2013). Biogenic synthesis of metallic nanoparticles by plant extracts. ACS Sustain. Chem. Eng. 1, 591-602. doi: 10.1021/sc300118u
3. Almeida, J. P. M., Figueroa, E. R., and Drezek, R. A. (2014). Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10, 503-514. doi: 10.1016/j.nano.2013.09.011
4. Amendola, V., and Meneghetti, M. (2009). Size evaluation of gold nanoparticles by UV-vis spectroscopy. J. Phys. Chem. C 113, 4277-4285. doi: 10.1021/jp8082425
5. "Antibiotic Resistance Threats in the United States, 2013" (2015). Antibiotic/Antimicrobial Resistance. USA: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/(accessed March 19, 2015).
6. "Antibiotic Resistance: An Ecological Perspective on an Old Problem" (2015). General Microbiology. USA: American Academy of Microbiology. Available at: http://academy.asm.org/index.php/general-microbiology/420-antibiotic-resistance-an-ecological-perspective-on-an-old-problem (accessed March 19, 2015).
7. Arakha, M., Mohammed, S., Mallick, B. C., and Jha, S. (2015). The effects of interfacial potential on antimicrobial propensity of ZnO nanoparticle. Sci. Rep. 5, 9578. doi: 10.1038/srep09578
8. Arias, C. A., and Murray, B. E. (2012). The rise of the enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266-278. doi: 10.1038/nrmicro2761
9. Badwaik, V. D., Bartonojo, J. J., Evans, J. W., Sahi, S. V., Willis, C. B., and Dakshinamurthy, R. (2011). Single-step biofriendly synthesis of surface modifiable, near-spherical gold nanoparticles for applications in biological detection and catalysis. Langmuir 27, 5549-5554. doi: 10.1021/la105041d
10. Badwaik, V. D., Willis, C. B., Pender, D. S., Paripelly, R., Shah, M., Kherde, Y. A., et al. (2013). Antibacterial gold nanoparticles-biomass assisted synthesis and characterization. J. Biomed. Nanotechnol. 9, 1716-1723. doi: 10.1166/jbn.2013.1666
11. Bao, G., Mitragotri, S., and Tong, S. (2013). Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng. 15, 253-282. doi: 10.1146/annurev-bioeng-071812-152409
12. Bennadi, D. (2013). Self-medication: a current challenge. J. Basic Clin. Pharm. 5, 19-23. doi: 10.4103/0976-0105.128253
13. Bhattacharya, D., Saha, B., Mukherjee, A., Santra, C. R., and Karmakar, P. (2012). Gold nanoparticles conjugated antibiotics: stability and functional evaluation. Nanosci. Nanotechnol. 2, 14-21. doi: 10.5923/j.nn.20120202.04
14. Bindhu, M. R., and Umadevi, M. (2014). Antibacterial activities of green synthesized gold nanoparticles. Mater. Lett. 120, 122-125. doi: 10.1016/j.matlet.2014.01.108
15. Brown, A. N., Smith, K., Samuels, T. A., Lu, J., Obare, S. O., and Scott, M. E. (2012). Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl. Environ. Microbiol. 78, 2768-2774. doi: 10.1128/AEM.06513-11
16. Burygin, G. L., Khlebtsov, B. N., Shantrokha, A. N., Dykman, L. A., Bogatyrev, V. A., and Khlebtsov, N. G. (2009). On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res. Lett. 4, 794-801. doi: 10.1007/s11671-009-93168
17. Chernousova, S., and Epple, M. (2013). Silver as antibacterial agent: ion, nanoparticle, and metal. Angew. Chem. Int. Ed. 52, 1636-1653. doi: 10.1002/anie.201205923
18. Clatworthy, A. E., Pierson, E., and Hung, D. T. (2007). Targeting virulence: a new paradigm for antimicrobial therapy. Nat. Chem. Biol. 3, 541-548. doi: 10.1038/nchembio.2007.24
19. Dakshinamurthy, R., and Sahi, S. (2012). Monodisperse Gold Nanoparticles and Facile, Environmentally Favorable Process for their Manufacture. US8257670 B1. Washington, DC: U.S. Patent and Trademark Office.
20. Dickson, J. S., and Koohmaraie, M. (1989). Cell surface charge characteristics and their relationship to bacterial attachment to meat surfaces. Appl. Environ. Microbiol. 55, 832-836.
21. Drbohlavova, J., Chomoucka, J., Adam, V., Ryvolova, M., Eckschlager, T., Hubalek, J., et al. (2013). Nanocarriers for anticancer drugs-new trends in nanomedicine. Curr. Drug Metab. 14, 547-564. doi: 10.2174/1389200211314050005
22. Finkelstein, A. E., Walz, D. T., Batista, V., Mizraji, M., Roisman, F., and Misher, A. (1976). Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann. Rheum. Dis. 35, 251-257. doi: 10.1136/ard.35.3.251
23. Haiss, W., Thanh, N. T. K., Aveyard, J., and Fernig, D. G. (2007). Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal. Chem. 79, 4215-4221. doi: 10.1021/ac0702084
24. Ivanov, M. R., Bednar, H. R., and Haes, A. J. (2009). Investigations of the mechanism of gold nanoparticle stability and surface functionalization in capillary electrophoresis. ACS Nano 3, 386-394. doi: 10.1021/nn8005619
25. Jiang, S., Win, K. Y., Liu, S., Teng, C. P., Zheng, Y., and Han, M.-Y. (2013). Surface-functionalized nanoparticles for biosensing and imaging-guided therapeutics. Nanoscale 5, 3127-3148. doi: 10.1039/c3nr34005h
26. Jugheli, L., Bzekalava, N., Rijk, P. D., Fissette, K., Portaels, F., and Rigouts, L. (2009). High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob. Agents Chemother. 53, 5064-5068. doi: 10.1128/AAC.00851-09
27. Khan, M. S., Vishakante, G. D., and Siddaramaiah, H. (2013). Gold nanoparticles: a paradigm shift in biomedical applications. Adv. Colloid Interface Sci. 199-200, 44-58. doi: 10.1016/j.cis.2013.06.003
28. Khlebtsov, N., Bogatyrev, V., Dykman, L., Khlebtsov, B., Staroverov, S., Shirokov, A., et al. (2013). Analytical and theranostic applications of gold nanoparticles and multifunctional nanocomposites. Theranostics 3, 167-180. doi: 10.7150/thno.5716
29. Kimling, J., Maier, M., Okenve, B., Kotaidis, V., Ballot, H., and Plech, A. (2006). Turkevich method for gold nanoparticle synthesis revisited. J. Phys. Chem. B 110, 15700-15707. doi: 10.1021/jp061667w
30. Kumar, D., Saini, N., Jain, N., Sareen, R., and Pandit, V. (2013). Gold nanoparticles: an era in bionanotechnology. Expert Opin. Drug Deliv. 10, 397-409. doi: 10.1517/17425247.2013.749854
31. Lawrenz, M. B., Biller, A. E., Cramer, D. E., Kraenzle, J. L., Sotsky, J. B., Vanover, C. D., et al. (2015). Development and evaluation of murine lung-specific disease models for Pseudomonas aeruginosa applicable to therapeutic testing. Pathog. Dis. 73:ftv025. doi: 10.1093/femspd/ftv025
32. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., et al. (2013). Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13, 1057-1098. doi: 10.1016/S1473-3099(13)70318-9
33. Liao, J., Tingting, Q., Bingyang, C., Jinrong, P., Feng, L., and Zhiyong, Q. (2014). Multifunctional nanostructured materials for multimodal cancer imaging and therapy. J. Nanosci. Nanotechnol. 14, 175-189. doi: 10.1166/jnn.2014.9049
34. Lima, E., Roberto, G., Víctor, L., and Ariel, G. (2013). Gold nanoparticles as efficient antimicrobial agents for Escherichia coli and Salmonella typhi. Chem. Cent. J. 7, 1-7. doi: 10.1186/1752-153X-7-11
35. Nanotechnology Characterization Laboratory (2009). Measuring Zeta Potential of Nanoparticles, NCL Method PCC-2. Frederick, MD: National Cancer Institute-Frederick.
36. National Committee for Clinical Laboratory Standards (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents. Wayne, PA: National Committee for Clinical Laboratory Standards.
37. National Committee for Clinical Laboratory Standards (2015). M100-S25: Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. 2015. Villanova, PA: National Committee for Clinical Laboratory Standards.
38. National Historic Chemical Landmarks program (1999). Discovery and Development of Penicillin. American Chemical Society. Available at: http://www.acs.org/content/dam/acsorg/education/whatischemistry/landmarks/flemingpenicillin/the-discovery-and-development-of-penicillin-commemorative-booklet.pdf
39. "News Feature: A Call to Arms". (2007). News feature: a call to arms. Nat. Rev. Drug Discov. 6, 8-12. doi: 10.1038/nrd2225
40. Ortiz-Benitez, E. A., Carrillo-Morales, M., Velázquez-Guadarrama, N., Fandiño-Armas, J., and de Jesús Olivares-Trejo, J. (2015). Inclusion bodies and pH lowering: as an effect of gold nanoparticles in Streptococcus pneumoniae. Metallomics 7, 1173-1179. doi: 10.1039/C5MT00044K
41. Pender, S. D., Vangala, L. M., Badwaik, V. D., Thompson, H., Paripelly, R., and Dakshinamurthy, R. (2013). A new class of gold nanoantibiotics-direct coating of ampicillin on gold nanoparticles. Pharm. Nanotechnol. 1, 126-135. doi: 10.2174/2211738511301020008
42. Seil, J. T., and Webster, T. J. (2012). Antimicrobial applications of nanotechnology: methods and literature. Int. J. Nanomed. 7, 2767-2781. doi: 10.2147/IJN.S24805
43. Shah, M., Badwaik, V., Kherde, Y., Waghwani, H. K., Modi, T., Aguilar, Z. P., et al. (2014). Gold nanoparticles: various methods of synthesis and antibacterial applications. Front. Biosci. 19:1320. doi: 10.2741/4284
44. Shedbalkar, U., Richa, S., Sweety, W., Sharvari, G., and Chopade, B. A. (2014). Microbial synthesis of gold nanoparticles: current status and future prospects. Adv. Colloid Interf. Sci. 209C, 40-48. doi: 10.1016/j.cis.2013.12.011
45. Silhavy, T. J., Kahne, D., and Walker, S. (2010). The bacterial cell envelope. Cold Spring Harb. Perspect. Biol. 2:a000414. doi: 10.1101/cshperspect.a000414
46. Stanier, C. (2014). Nontoxic Nanoparticles-MaterialsViews. Available at: http://www.materialsviews.com/nontoxic-nanoparticles/(accessed June 21, 2014).
47. Sun, Y., Connor, M. G., Pennington, J. M., and Lawrenz, M. B. (2012). Development of bioluminescent bioreporters for in vitro and in vivo tracking of Yersinia pestis. PLoS ONE 7:e47123. doi: 10.1371/journal.pone.0047123
48. Sutradhar, K., Bishwajit, A. S., Naz, H. H., and Riaz, U. (2014). Irrational use of antibiotics and antibiotic resistance in southern rural Bangladesh: perspectives from both the physicians and patients. Annu. Res. Rev. Biol. 4, 1421-1430. doi: 10.9734/ARRB/2014/8184
49. Tillotson, G. S., and Theriault, N. (2013). New and alternative approaches to tackling antibiotic resistance. F1000Prime Rep. 5:51. doi: 10.12703/P5-51
50. Tiwari, P. M., Komal, V., Dennis, V. A., and Singh, S. R. (2011). Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1, 31-63. doi: 10.3390/nano1010031
51. Torchilin, V. P. (ed.) (2014). Handbook of Nanobiomedical Research: Fundamentals, Applications, and Recent Developments. Frontiers in Nanobiomedical Research, Vol. 3. Hackensack, NJ: World Scientific Publishing.
52. Turkevich, J., Peter, C. S., and James, H. (1951). A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11, 55-75. doi: 10.1039/df9511100055
53. Umezawa, H. (1958). Kanamycin: its discovery. Ann. N. Y. Acad. Sci. 76, 20-26. doi: 10.1111/j.1749-6632.1958.tb54688.x
54. Voliani, V., Giovanni, S., Riccardo, N., Fernanda, R., Stefano, L., and Fabio, B. (2012). Smart delivery and controlled drug release with gold nanoparticles: new frontiers in nanomedicine. Recent Pat. Nanomed. 2, 34-44. doi: 10.2174/1877913111202010034
55. Who | Antimicrobial Resistance (2014). WHO. Available at: http://www.who.int/mediacentre/factsheets/fs194/en/(accessed June 27, 2014).
56. Wiegand, I., Kai, H., and Hancock, R. E. W. (2008). Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protoc. 3, 163-175. doi: 10.1038/nprot.2007.521
57. "World Economic Forum-Global Risks 2013 Eighth Edition" (2014). Global Risks 2013 Eighth Edition." The World Economic Forum. Available at: http://reports.weforum.org/global-risks-2013/view/risk-case-1/the-dangers-of-hubris-on-human-health/(accessed June 16, 2014).
58. World Health Organization [WHO] (2015). Antimicrobial Resistance: Global Report on Surveillance 2014. WHO. Available at: http://www.who.int/drugresistance/documents/surveillancereport/en/(accessed March 19, 2015).
59. Xie, J., Talaska, A. E., and Schacht, J. (2011). New developments in aminoglycoside therapy and ototoxicity. Hear. Res. 281, 28-37. doi: 10.1016/j.heares.2011.05.008
60. Zhang, J., Bo, L., Huixia, L., Xiaobing, Z., and Weihong, T. (2013). Aptamer-conjugated gold nanoparticles for bioanalysis. Nanomedicine (Lond.) 8, 983-993. doi: 10.2217/nnm.13.80
61. Zhao, Y., and Jiang, X. (2013). Multiple strategies to activate gold nanoparticles as antibiotics. Nanoscale 5, 8340-8350. doi: 10.1039/C3NR01990J
62. Zhao, Y., Tian, Y., Cui, Y., Liu, W., Ma, W., and Jiang, X. (2010). Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J. Am. Chem. Soc. 132, 12349-12356. doi: 10.1021/ja1028843
63. Zhou, C., Shengyang, Y., Jinbin, L., Mengxiao, Y., and Jie, Z. (2013). Luminescent gold nanoparticles: a new class of nanoprobes for biomedical imaging. Exp. Biol. Med. (Maywood) 238, 1199-1209. doi: 10.1177/1535370213505825
64. Zhou, Y., Ying, K., Subrata, K., Cirillo, J. D., and Hong, L. (2012). Antibacterial activities of gold and silver nanoparticles against Escherichia coli and Bacillus Calmette-Guérin. J. Nanobiotechnol. 10, 1-9. doi: 10.1186/1477-3155-10-19